过去一年中添加的文章，按日期排序
[HTML][HTML] Chemotherapy increases CDA expression and sensitizes malignant pleural mesothelioma cells to capecitabine treatment
D Karatkevich, T Losmanova, P Zens, H Deng… - Scientific Reports, 2024 - nature.com
1 天前 - … MPM and lung cancer. A subset of matched patient samples showed increased
CDA expression after therapy, suggesting that a schedule-dependent treatment strategy based …
CDA expression after therapy, suggesting that a schedule-dependent treatment strategy based …
CD27 signaling inhibits tumor growth and metastasis via CD8+ T cell-independent mechanisms in the B16-F10 melanoma model
ER Puppala, L Wu, X Fan… - Cancer immunology …, 2024 - pubmed.ncbi.nlm.nih.gov
1 天前 - … CD27 stimulation enhances T cell survival and effector functions, thus providing
opportunities to develop therapeutic strategies. The current study aims to investigate the role of …
opportunities to develop therapeutic strategies. The current study aims to investigate the role of …
[HTML][HTML] The global landscape of clinical trials and drug discovery for brain metastasis
J Ding, Y Jiang, J Zhou, Q Tang… - Journal of …, 2024 - … -medicine.biomedcentral.com
1 天前 - … Due to the biological heterogeneity, the potential differences in BrM between cancer
types should receive more attention. With research on novel therapeutic strategies against …
types should receive more attention. With research on novel therapeutic strategies against …
Enzyme-activated binary assembly for targeted, controlled delivery of anti-liver cancer compounds
D Wang, X Chen, S Chen, H Wang, J Yang, J He… - Carbohydrate …, 2024 - Elsevier
2 天前 - … accessory method that can enhance the therapeutic efficacy of HCPT while exhibiting
… offers a promising strategy for the effective use of HCPT in the treatment of liver cancer. …
… offers a promising strategy for the effective use of HCPT in the treatment of liver cancer. …
Strategies for Enhancing Non-small Cell Lung Cancer Treatment: Integrating Chinese Herbal Medicines with Epidermal Growth Factor Receptor-Tyrosine Kinase …
L Chen, WD Chen, YX Xu, YY Ren, C Zheng… - European Journal of …, 2024 - Elsevier
2 天前 - … Non-small cell lung cancer (NSCLC) poses a global … Additionally, the review
introduces a therapeutic strategy … of CHMs in combination therapy for NSCLC management, …
introduces a therapeutic strategy … of CHMs in combination therapy for NSCLC management, …
Au Nanoclusters Embedded in Polydopamine for Photothermal Radiotherapy on Non-Small-Cell Lung Cancer
P Hu, X Tian, Z Sun, X Yu, X Wei, H Jiang… - ACS Applied Nano …, 2024 - ACS Publications
2 天前 - … To improve the therapeutic potential and reduce unwanted damage … therapies have
been proposed that combine RT with various other strategies, such as photothermal therapy …
been proposed that combine RT with various other strategies, such as photothermal therapy …
[HTML][HTML] Early-Stage Non-Small Cell Lung Cancer: New Challenges with Immune Checkpoint Blockers and Targeted Therapies
P Lavaud, M Bortolot, L Zullo, D O'Reilly, J Naidoo… - Cancers, 2024 - mdpi.com
2 天前 - … The current review summarizes the new potential treatment strategies for patients
with early-stage non-small cell lung cancer with immunotherapy and targeted therapies and …
with early-stage non-small cell lung cancer with immunotherapy and targeted therapies and …
[HTML][HTML] Adverse Events in Osimertinib Treatment for EGFR-Mutated Non-Small-Cell Lung Cancer: Unveiling Rare Life-Threatening Myelosuppression
W Shalata, A Abu Jama, Y Dudnik, O Abu Saleh… - Medicina, 2024 - mdpi.com
2 天前 - … Recent advancements in targeted therapies for non-small-cell lung cancer (NSCLC), …
, have revolutionized treatment strategies. Osimertinib, an approved therapy for metastatic …
, have revolutionized treatment strategies. Osimertinib, an approved therapy for metastatic …
Targeted degradation of KRAS protein in non-small cell lung cancer: Therapeutic strategies using liposomal PROTACs with enhanced cellular uptake and …
X Wang, L Su, C Niu, X Li, R Wang… - Drug development …, 2024 - pubmed.ncbi.nlm.nih.gov
2 天前 - … The role of KRAS mutation in non-small cell lung cancer (NSCLC) initiation and …
This study contributed to the exploration of enhanced therapeutic strategies for NSCLC, …
This study contributed to the exploration of enhanced therapeutic strategies for NSCLC, …
Personalized Immunotherapy Achieves Complete Response in Metastatic Adenoid Cystic Carcinoma Despite Lack of Conventional Biomarkers
2 天前 - … therapeutics. … cancer (CRC) were found to be a predictive biomarker of favorable
response to ICI[48,49], whereas it was elevated NOTCH signaling in small cell lung cancer[50]. …
response to ICI[48,49], whereas it was elevated NOTCH signaling in small cell lung cancer[50]. …